DRW Securities’s Evoke Pharma EVOK Stock Holding History

DRW Securities’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,742	Closed	-$118K	–	1371
2025 Q3	$118K	Buy	+23,742	New	+$118K	﹤0.01%	1169

DRW Securities's EVOK Position: Q4 2025 in Review

DRW Securities sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 23,742 shares — an estimated $118K sold.

DRW Securities first reported a position in EVOK in Q3 2025 and held it in 1 quarter. The position peaked at $118K in Q3 2025. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.

DRW Securities reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
DRW Securities sold 23,742 Evoke Pharma shares in Q4 2025, an estimated $118K.
DRW Securities first reported a position in Evoke Pharma in Q3 2025 and held it in 1 quarter.
DRW Securities's Evoke Pharma position peaked at $118K in Q3 2025.
0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.